Drugs / Follitropin Alfa Biosimilar
last change May 2023 re-read 2 minutes ago

Follitropin Alfa Biosimilar

Developed for
infertility disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05815719 Comparator Nov 2022 → Apr 2023 infertility disorder Instituto Bernabeu Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Follitropin Alfa Biosimilar ClinicalTrials.gov intervention name — accepted as the source's own label NCT05815719